New anxiety drug shows promise in early brain study
Symptom relief
Not yet recruiting
This study tests a single dose of an experimental drug called SYT-510 in 24 adults with generalized anxiety disorder. Researchers will use brain scans and behavioral tasks to see if the drug reduces anxiety and changes how the brain responds to threats. The goal is to gather info…
Phase: PHASE2 • Sponsor: Synendos Therapeutics AG • Aim: Symptom relief
Last updated May 18, 2026 08:14 UTC